Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation
Open Access
- 10 February 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Genome Medicine
- Vol. 13 (1), 1-12
- https://doi.org/10.1186/s13073-021-00837-7
Abstract
Epigenetic alterations are associated with normal biological processes such as aging or differentiation. Changes in global epigenetic signatures, together with genetic alterations, are driving events in several diseases including cancer. Comparative studies of cancer and healthy tissues found alterations in patterns of DNA methylation, histone posttranslational modifications, and changes in chromatin accessibility. Driven by sophisticated, next-generation sequencing-based technologies, recent studies discovered cancer epigenomes to be dominated by epigenetic patterns already present in the cell-of-origin, which transformed into a neoplastic cell. Tumor-specific epigenetic changes therefore need to be redefined and factors influencing epigenetic patterns need to be studied to unmask truly disease-specific alterations. The underlying mechanisms inducing cancer-associated epigenetic alterations are poorly understood. Studies of mutated epigenetic modifiers, enzymes that write, read, or edit epigenetic patterns, or mutated chromatin components, for example oncohistones, help to provide functional insights on how cancer epigenomes arise. In this review, we highlight the importance and define challenges of proper control tissues and cell populations to exploit cancer epigenomes. We summarize recent advances describing mechanisms leading to epigenetic changes in tumorigenesis and briefly discuss advances in investigating their translational potential.Keywords
Funding Information
- Deutschen Konsortium für Translationale Krebsforschung
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Helmholtz-Gemeinschaft
- Deutsches Krebsforschungszentrum
This publication has 106 references indexed in Scilit:
- Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR InhibitionPLOS ONE, 2013
- DNA methylation arrays as surrogate measures of cell mixture distributionBMC Bioinformatics, 2012
- A DNA hypermethylation module for the stem/progenitor cell signature of cancerGenome Research, 2012
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeNature, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal CarcinogenesisPLoS Genetics, 2011
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspectiveActa Neuropathologica, 2010
- Distinct Epigenomic Landscapes of Pluripotent and Lineage-Committed Human CellsCell Stem Cell, 2010
- Global histone modification patterns predict risk of prostate cancer recurrenceNature, 2005
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005